Molecular Templates, Inc. Business Operations Contracts & Agreements
14 Contracts & Agreements
- Advisory Agreements (2 contracts)
- Collaboration Agreements (5)
- Indemnification Agreements (3)
- Sales Agreements (3)
- Termination Agreements (1)
- Amendment No. 1 to Collaboration Agreement, dated December 2, 2021, by and between the Company and Bristol-Myers Squibb Company (Filed With SEC on March 29, 2022)
- Collaboration Agreement by and between Molecular Templates, Inc. and Bristol-Myers Squibb Company dated February 10, 2021 (Filed With SEC on May 14, 2021)
- Sales Agreement, dated August 7, 2020, by and between Molecular Templates, Inc. and Cowen and Company, LLC (Filed With SEC on August 7, 2020)
- First Amendment to the Development Collaboration and Exclusive License Agreement, dated as of July 18, 2019, by and between Molecular Templates, Inc. and Millennium... (Filed With SEC on November 12, 2019)
- Multi-License Collaboration and License Agreement, dated June 23, 2017, between Molecular Templates OpCo and Millennium Pharmaceuticals, Inc. (a wholly owned subsidiary of Takeda... (Filed With SEC on October 17, 2017)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on August 7, 2017)
- MOLECULAR TEMPLATES, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on May 15, 2017)
- CONFIDENTIAL TREATMENT REQUESTED Research Collaboration and Option Agreement (Filed With SEC on May 15, 2017)
- TERMINATION AND RETURN OF RIGHTS AGREEMENT (Filed With SEC on May 5, 2016)
- THRESHOLD PHARMACEUTICALS, INC. $50,000,000 SALES AGREEMENT (Filed With SEC on November 2, 2015)
- THRESHOLD PHARMACEUTICALS, INC. ADVISORY BOARD AGREEMENT (Filed With SEC on May 1, 2014)
- First Amendment to At Market Issuance Sales Agreement (Filed With SEC on January 20, 2012)
- THRESHOLD PHARMACEUTICALS, INC. ADVISORY BOARD AGREEMENT (Filed With SEC on March 15, 2007)
- INDEMNIFICATION AGREEMENT (Filed With SEC on December 6, 2004)
